Log in or Sign up for Free to view tailored content for your specialty!
Practice Management News
Pact allows ACA to require preventive services amid legal battle
The U.S. government can continue requiring insurance plans to cover services, including HIV prevention and certain cancer screenings, while legal proceedings over Affordable Care Act mandates continue, the Associated Press reported.
Houston makes space for ASM Microbe
Houston is making space for the largest microbial sciences conference in the world.
Log in or Sign up for Free to view tailored content for your specialty!
Q&A: New AMA president optimistic despite 'health care system in crisis'
Jesse M. Ehrenfeld, MD, MPH, FAMIA, FASA, was recently sworn in as president of the AMA.
AMA votes to oppose noncompete agreements in certain physician contracts
During its House of Delegates meeting, the AMA voted to oppose noncompete agreements for physicians employed by hospitals or staffing company employers.
Relationship between interest rates, S&P 500 performance is complex
Many investors have recently been asking their advisors, “Is a recession coming?” This question is often on the minds of investors because the financial media repeatedly brings up the topic.
Changes on horizon may help lessen C. difficile burden
The COVID-19 pandemic underscored challenges in the prevention and treatment of health care-associated infections.
HHS announces savings on 43 prescription drugs for Medicare Part B beneficiaries
HHS has released a list of 43 prescription drugs for which Part B beneficiary coinsurances may be lower starting July 1.
BPaL a ‘game-changer’ for treatment of drug-resistant tuberculosis
BPaL shortens treatment times significantly and shows few adverse effects in patients with drug-resistant tuberculosis , according to data published in Clinical Infectious Diseases.
Reusing disposable masks has no major impact on skin, upper respiratory microbiome
Reusing single-use surgical masks for up to a week had no major impact on skin or upper respiratory tract microbiomes, according to data published in The Journal of Infectious Diseases.
FDA advisors recommend monoclonal antibody to protect infants from RSV
An FDA advisory committee on Thursday voted in favor of approving the long-acting monoclonal antibody nirsevimab to protect neonates and infants from respiratory syncytial virus.
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read